Stocks


 Why Lynas Rare Earths Could Shape the ASX 200 Narrative

Why Lynas Rare Earths Could Shape the ASX 200 Narrative

March 29, 2026 04:13 AM AEDT| By Sam

Rare earth demand and evolving market dynamics continue to reshape valuation perspectives, highlighting the growing importance of strategic resources in Australia’s equity landscape and their influence on broader market trends.

 ANZ Banking Group ASX 200 Key Metrics Overview

ANZ Banking Group ASX 200 Key Metrics Overview

March 28, 2026 05:41 PM AEDT| By Sam

ANZ Banking Group highlights core financial metrics including lending, deposits, and capital structure, reflecting its role within the ASX 200 financial sector.

 Bendigo Bank Gains ASX 100 Focus in All Ordinaries

Bendigo Bank Gains ASX 100 Focus in All Ordinaries

March 28, 2026 05:30 PM AEDT| By Sam

Bendigo Bank reflects regional banking operations within the financial sector, highlighting valuation frameworks and its position across ASX 100 and All Ordinaries indices.

 Transurban ASX 200 Industrials Sector Market Focus

Transurban ASX 200 Industrials Sector Market Focus

March 28, 2026 05:27 PM AEDT| By Sam

Transurban highlights industrials sector activity through infrastructure operations, reflecting its role within ASX indices and broader market connectivity.

 Woolworths ASX 20 Update Reflects Retail Sector Strength

Woolworths ASX 20 Update Reflects Retail Sector Strength

March 28, 2026 05:22 PM AEDT| By Team Kalkine Media

Woolworths reflects ASX retail sector activity through supply chain strength, consumer demand, and digital integration across ASX 20 and ASX 300 indices.

 Is BHP (ASX:BHP) steadying ASX 200 market trends?

Is BHP (ASX:BHP) steadying ASX 200 market trends?

March 28, 2026 05:13 PM AEDT| By Sam

Australian market reflects balanced sector participation, with BHP and financials contributing to ASX 200 and All Ordinaries market stability.

 ASX 200 Updates: SOL (ASX:SOL) Group Portfolio Focus

ASX 200 Updates: SOL (ASX:SOL) Group Portfolio Focus

March 28, 2026 05:09 PM AEDT| By Sam

Washington H Soul Pattinson highlights diversified portfolio exposure across industries, reflecting structured investment participation within the ASX 200.

 4DMedical Rallies as Expansion Story Gains Traction

4DMedical Rallies as Expansion Story Gains Traction

March 27, 2026 09:05 PM AEDT| By Sam

4DMedical re-enters focus after a capital raise, with its imaging innovation and expansion strategy shaping valuation discussions and market sentiment.

 Lynas Rare Earths: Powering Global Supply Shift

Lynas Rare Earths: Powering Global Supply Shift

March 27, 2026 09:00 PM AEDT| By Sam

Lynas Rare Earths strengthens its global footprint as a key rare earth supplier, supporting clean energy, technology, and supply chain diversification trends worldwide.

 NAB’s Offshore Strategy Reshapes Long-Term Outlook

NAB’s Offshore Strategy Reshapes Long-Term Outlook

March 27, 2026 08:55 PM AEDT| By Sam

NAB’s offshore hiring and restructuring strategy signals a shift in cost efficiency and long-term risk outlook, shaping its position within Australia’s evolving banking sector.

 BHP vs QBE: Which ASX Giant Stands Out in 2026?

BHP vs QBE: Which ASX Giant Stands Out in 2026?

March 27, 2026 08:42 PM AEDT| By Sam

A detailed comparison of BHP and QBE explores valuation signals, business strength, and sector dynamics shaping their position within the Australian share market landscape.

 SHL vs XRO: Are Valuations Hinting at Opportunity?

SHL vs XRO: Are Valuations Hinting at Opportunity?

March 27, 2026 08:32 PM AEDT| By Sam

Sonic Healthcare and Xero shares trade below historical valuation levels, highlighting changing market sentiment, revenue trends, and evolving dynamics across healthcare and cloud software sectors.

 ResMed & Netwealth: A Fresh Look at Valuation Trends

ResMed & Netwealth: A Fresh Look at Valuation Trends

March 27, 2026 07:54 PM AEDT| By Sam

ResMed and Netwealth shares are drawing attention as valuation metrics shift below historical trends, offering insights into business resilience and evolving market dynamics.

 Why Materials Shares Stay in Focus: PLS Insight

Why Materials Shares Stay in Focus: PLS Insight

March 27, 2026 07:17 PM AEDT| By Sam

Materials stocks remain in focus as lithium demand rises, with Pilbara Minerals gaining attention for its role in battery supply chains and evolving growth-driven market positioning.

 WBC Share Value Check: 2 Key Valuation Methods

WBC Share Value Check: 2 Key Valuation Methods

March 27, 2026 07:09 PM AEDT| By Sam

A detailed look at WBC valuation using earnings and dividend models, along with key factors influencing ASX banking sector insights.

 Downer EDI Shares in Focus: Value Signals for 2026

Downer EDI Shares in Focus: Value Signals for 2026

March 27, 2026 06:13 PM AEDT| By Sam

Downer EDI Ltd share price analysis covering revenue trends, margins, debt, and dividends, offering insights into valuation outlook within the infrastructure sector.

 Bendigo Bank Share Price: Key Valuation Insights

Bendigo Bank Share Price: Key Valuation Insights

March 27, 2026 06:05 PM AEDT| By Sam

A detailed look at Bendigo Bank share price valuation, covering lending margins, capital strength, culture insights, and dividend models shaping long-term outlook.

 Titomic Strengthens Europe Footprint with Aerospace Deal

Titomic Strengthens Europe Footprint with Aerospace Deal

March 27, 2026 05:55 PM AEDT| By Sam

Titomic Limited strengthens its European footprint through an aerospace collaboration, enhancing adoption of cold spray technology across research, defence, and advanced manufacturing sectors.

 ASX Holds Weekly Ground Despite Late Session Dip

ASX Holds Weekly Ground Despite Late Session Dip

March 27, 2026 05:31 PM AEDT| By Sam

ASX closes steady amid global weakness as energy leads gains while defensive sectors provide stability, highlighting shifting market trends and key corporate updates.

 Lumos Diagnostics Gains FDA Nod to Expand US Reach

Lumos Diagnostics Gains FDA Nod to Expand US Reach

March 27, 2026 05:20 PM AEDT| By Sam

Lumos Diagnostics advances US expansion after regulatory clearance, enabling wider clinical adoption of its rapid test and supporting growth through strategic funding and operational scale-up.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.